175 related articles for article (PubMed ID: 24745190)
1. [Papillomavirus in the genesis of oral leukoplakia].
Babichenko II; Rabinovich OF; Ivina AA; Rabinovich IM; Togonidze AA
Arkh Patol; 2014; 76(1):32-6. PubMed ID: 24745190
[TBL] [Abstract][Full Text] [Related]
2. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
Greer RO; Meyers A; Said SM; Shroyer KR
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification.
Acay R; Rezende N; Fontes A; Aburad A; Nunes F; Sousa S
Oral Microbiol Immunol; 2008 Aug; 23(4):271-4. PubMed ID: 18582325
[TBL] [Abstract][Full Text] [Related]
4. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
5. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
6. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation.
Yang SW; Lee YS; Chen TA; Wu CJ; Tsai CN
Cancer Epidemiol; 2009 Aug; 33(2):118-22. PubMed ID: 19679058
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus in oral squamous cell carcinoma, leukoplakia and lichen planus in Thai patients.
Khovidhunkit SO; Buajeeb W; Sanguansin S; Poomsawat S; Weerapradist W
Asian Pac J Cancer Prev; 2008; 9(4):771-5. PubMed ID: 19256774
[TBL] [Abstract][Full Text] [Related]
9. [Precancers of the oral mucosa: clinic, diagnostics].
Rabinovich OF; Rabinovich IM; Babichenko II; Umarova KV; Bekmurzova LF
Stomatologiia (Mosk); 2024; 103(2):5-11. PubMed ID: 38741528
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Nemes JA; Deli L; Nemes Z; Márton IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia.
Cunningham LL; Pagano GM; Li M; Tandon R; Holm SW; White DK; Lele SM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):77-81. PubMed ID: 16831676
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus subtypes in oral lesions compared to healthy oral mucosa.
Kristoffersen AK; Enersen M; Kverndokk E; Sunde PT; Landin M; Solheim T; Olsen I; Grinde B
J Clin Virol; 2012 Apr; 53(4):364-6. PubMed ID: 22261124
[TBL] [Abstract][Full Text] [Related]
13. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions.
Campisi G; Di Fede O; Giovannelli L; Capra G; Greco I; Calvino F; Maria Florena A; Lo Muzio L
Oral Oncol; 2005 Nov; 41(10):994-1004. PubMed ID: 16129653
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
15. Genotypic determination by PCR-RFLP of human papillomavirus in normal oral mucosa, oral leukoplakia and oral squamous cell carcinoma samples in Madrid (Spain).
Llamas-Martínez S; Esparza-Gómez G; Campo-Trapero J; Cancela-Rodríguez P; Bascones-Martínez A; Moreno-López LA; García-Núñez JA; Cerero-Lapiedra R
Anticancer Res; 2008; 28(6A):3733-41. PubMed ID: 19189658
[TBL] [Abstract][Full Text] [Related]
16. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer.
Angiero F; Gatta LB; Seramondi R; Berenzi A; Benetti A; Magistro S; Ordesi P; Grigolato P; Dessy E
Anticancer Res; 2010 Sep; 30(9):3435-40. PubMed ID: 20944119
[TBL] [Abstract][Full Text] [Related]
17. Proliferative verrucous leukoplakia: a concise update.
Bagan J; Scully C; Jimenez Y; Martorell M
Oral Dis; 2010 May; 16(4):328-32. PubMed ID: 20233330
[TBL] [Abstract][Full Text] [Related]
18. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
19. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples.
Majumder M; Indra D; Roy PD; Datta S; Ray JG; Panda CK; Roy B
J Oral Pathol Med; 2009 Feb; 38(2):174-80. PubMed ID: 18764855
[TBL] [Abstract][Full Text] [Related]
20. Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Sundberg J; Korytowska M; Burgos PM; Blomgren J; Blomstrand L; DE Lara S; Sand L; Hirsch JM; Holmberg E; Giglio D; Öhman J; Kovács A; Horal P; Lindh M; Kjeller G; Hasséus B
Anticancer Res; 2019 Mar; 39(3):1293-1300. PubMed ID: 30842161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
